PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells

✍ Scribed by Ciro Zanca; Flora Cozzolino; Cristina Quintavalle; Stefania Di Costanzo; Lucia Ricci-Vitiani; Margherita Santoriello; Maria Monti; Piero Pucci; Gerolama Condorelli

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 363 KB
• Volume: 225
• Category: Article
• ISSN: 0021-9541
• DOI: 10.1002/jcp.22197

✦ Synopsis

Abstract

PED (phosphoprotein enriched in diabetes) is a 15 kDa protein involved in many cellular pathways and human diseases including type II diabetes and cancer. We recently reported that PED is overexpressed in human cancers and mediates resistance to induced apoptosis. To better understand its role in cancer, we investigated on PED interactome in non‐small cell lung cancer (NSCLC). By the Tandem Affinity Purification (TAP), we identified and characterized among others, Rac1, a member of mammalian Rho GTPase protein family, as PED‐interacting protein. In this study we show that PED coadiuvates Rac1 activation by regulating AKT mediated Rac1‐Ser^71^ phosphorylation. Furthermore, we show that the expression of a constitutively active Rac, affected PED‐Ser^104^ phosphorylation, which is important for PED‐regulated ERK 1/2 nuclear localization. Through specific Rac1‐siRNA or its pharmacological inhibition, we demonstrate that PED augments migration and invasion in a Rac1‐dependent manner in NSCLC. In conclusion, we show for the first time that PED and Rac1 interact and that this interaction modulates cell migration/invasion processes in cancer cells through ERK1/2 pathway. J. Cell. Physiol. 225: 63–72, 2010. © 2010 Wiley‐Liss, Inc.